Li Kang Biomedical Co Ltd (6242) — Net Asset Momentum
Li Kang Biomedical Co Ltd (6242) recorded a net asset momentum of 1.8% as of December 2025, with net assets of NT$871.24 Million TWD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 6242 total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Li Kang Biomedical Co Ltd Net Asset Momentum (2002–2025)
This chart tracks Li Kang Biomedical Co Ltd's year-over-year net asset growth across 24 annual reporting periods from 2002 to 2025. The most recent momentum reading is +1.8%, with net assets of NT$871.24 Million TWD as of December 2025. For live market cap and overall valuation, see Li Kang Biomedical Co Ltd market capitalisation.
Annual Net Asset History for Li Kang Biomedical Co Ltd (2002–2025)
The table below shows the complete annual net asset history for Li Kang Biomedical Co Ltd from 2002 to 2025, covering 24 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Li Kang Biomedical Co Ltd to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (TWD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | NT$871.24 Million | NT$1.09 Billion | NT$221.82 Million | ▲ +1.8% |
| 2024 | NT$855.68 Million | NT$1.04 Billion | NT$179.93 Million | ▲ +35.8% |
| 2023 | NT$630.03 Million | NT$827.00 Million | NT$196.97 Million | ▲ +10.5% |
| 2022 | NT$570.14 Million | NT$688.84 Million | NT$118.70 Million | ▲ +15.9% |
| 2021 | NT$492.00 Million | NT$616.07 Million | NT$124.07 Million | ▼ -3.2% |
| 2020 | NT$508.30 Million | NT$644.77 Million | NT$136.46 Million | ▲ +5.1% |
| 2019 | NT$483.44 Million | NT$626.44 Million | NT$143.00 Million | ▲ +3.5% |
| 2018 | NT$466.92 Million | NT$609.85 Million | NT$142.93 Million | ▲ +4.8% |
| 2017 | NT$445.68 Million | NT$596.06 Million | NT$150.38 Million | ▲ +30.8% |
| 2016 | NT$340.80 Million | NT$554.77 Million | NT$213.96 Million | ▲ +21.6% |
| 2015 | NT$280.29 Million | NT$526.73 Million | NT$246.44 Million | ▲ +23.2% |
| 2014 | NT$227.44 Million | NT$324.37 Million | NT$96.93 Million | ▲ +836.4% |
| 2013 | NT$24.29 Million | NT$111.79 Million | NT$87.50 Million | ▼ -71.5% |
| 2012 | NT$85.12 Million | NT$147.57 Million | NT$62.45 Million | ▼ -31.0% |
| 2011 | NT$123.43 Million | NT$182.81 Million | NT$59.37 Million | ▲ +18.3% |
| 2010 | NT$104.31 Million | NT$153.96 Million | NT$49.65 Million | ▼ -18.8% |
| 2009 | NT$128.49 Million | NT$252.83 Million | NT$124.35 Million | ▼ -32.8% |
| 2008 | NT$191.32 Million | NT$438.89 Million | NT$247.58 Million | ▼ -53.5% |
| 2007 | NT$411.54 Million | NT$701.86 Million | NT$290.32 Million | ▲ +90.6% |
| 2006 | NT$215.94 Million | NT$757.63 Million | NT$541.69 Million | ▼ -3.4% |
| 2005 | NT$223.45 Million | NT$791.11 Million | NT$567.66 Million | ▼ -30.9% |
| 2004 | NT$323.44 Million | NT$766.35 Million | NT$442.91 Million | ▼ -4.3% |
| 2003 | NT$338.06 Million | NT$770.15 Million | NT$432.09 Million | ▼ -2.8% |
| 2002 | NT$347.64 Million | NT$765.96 Million | NT$418.31 Million | — |